Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous thiamine for prevention or treatment of delirium in critically ill ICU patients
ISRCTN77931273Phase 2Recruiting
- Sponsor
- Intensive Care National Audit & Research Centre
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in delirium comparing Intravenous thiamine with Placebo (2 arms). Primary endpoint: Days alive and free of delirium and coma up to day 14. Started Sep 2026; status: recruiting.
02
Drugs
thiamine
03
Conditions
delirium
Beyond the preview
Go deeper on ISRCTN77931273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN77931273.